
Does it excite you to shape medical strategy and scientific exchange within obesity, and do you have experience driving impactful Medical Affairs work in a matrix organization? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As Associate Medical Director in Medical Projects – Obesity, the role supports Zealand Pharma’s obesity portfolio through medical leadership, scientific insight, and cross-functional collaboration. The position helps translate external medical developments into clear internal guidance and contributes to strong, compliant engagement with the medical/scientific community. This is an opportunity to help advance medical plans for new products and support strategic initiatives with internal stakeholders and partners.
We offer exciting responsibilities:
Your profile
The ideal candidate demonstrates strategic thinking and medical leadership, with the ability to deliver results and launch-relevant initiatives in a matrix environment. The role suits a collaborative team player who can work effectively across geographies and cultures and who communicates clearly and credibly with both internal and external stakeholders. Strong ethics, integrity, and a patient-focused mindset are essential.
Your new team
You will join the Medical Projects organization focused on Obesity and work closely with colleagues across R&D and other internal stakeholders. The team collaborates with internal experts and external medical/scientific communities to generate insights, shape medical strategy, and support scientific exchange across the obesity portfolio.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture. Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Interested in bonding with us? Then please apply no later than June 5, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
For further information, please contact Sr. Medical Director – Head of Medical Projects, Theis Gondolf @ tgondolf@zealandpharma.com
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com
#LI-Onsite

At Zealand Pharma, we are a Danish biotechnology company on a mission to change lives with next generation peptide medicines.
In our effort to reach our goals, bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other.
Ten drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market. Our current pipeline of internal product candidates focuses on obesity, chronic inflammation, and certain rare diseases.
Our leading obesity programs are backed by strong partners, including Roche and Boehringer Ingelheim.
We are based in Copenhagen (Søborg), Denmark, with a team in the U.S. For further information about our business and activities, please visit www.zealandpharma.com or bond with us through LinkedIn.